SCHEMBL25857635

SCHEMBL25857635

COc1cc(C)c(C(C)(C)C)c(C(C)(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
ALDH1A1 P00352 3/20 0.40
GAA P10253 1/20 0.39
CYP3A4 P08684 4/20 0.35
PTPN1 P18031 1/20 0.35
HPGD P15428 3/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34
TNFRSF1A P19438 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
TUBB1 Q9H4B7 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
CYP1A1 P04798 3/20 0.32
CYP1B1 Q16678 3/20 0.32
TTR P02766 2/20 0.32
ALOX5 P09917 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25946859 0.87 ALDH1A1 (0.48) CA1CA2ALDH1A1CYP3A4PTPN1
SCHEMBL26712983 0.86 CA1 (0.46) CA1CA2ALDH1A1GAACYP3A4
SCHEMBL24390668 0.79 CA1 (0.55) CA1CA2ALDH1A1GAACYP3A4
SCHEMBL15180056 0.79 CA1 (0.55) CA1CA2ALDH1A1GAACYP3A4
SCHEMBL18715652 0.78 CA2 (0.64) CA1CA2ALDH1A1GAACYP3A4
SCHEMBL10954074 0.78 CA2 (0.77) CA1CA2ALDH1A1GAACYP3A4
SCHEMBL25946862 0.78 TAAR1 (0.41) CA1CA2ALDH1A1CYP3A4PTPN1
SCHEMBL26710046 0.75 CA1 (0.37) CA1CA2ALDH1A1GAACYP3A4
SCHEMBL25868614 0.75 CYP3A4 (0.39) CA1CA2ALDH1A1CYP3A4PTPN1
Lithium Ion SCHEMBL6312687 0.74 CA1 (0.59) CA1CA2ALDH1A1GAACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912693-B2 Compounds for modulating S1P1 activity and methods of using the same TREVENA, INC. (US) 2024-02-27 US disclosed
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 CA1 3782/4885CA2 3359/4885ALDH1A1 2583/4885
US-11912693-B2 Compounds for modulating S1P1 activity and methods of using the same S1PR1, S1PR2, S1PR3 CA1 3782/4885CA2 3359/4885ALDH1A1 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.